Efficacy and Safety Profile of Long Term Exposure to Lenalidomide in Relapsed Multiple Myeloma

被引：0
|
作者：
Fouquet, Guillemette
Tardy, Stephanie [1 ]
Demarquette, Helene [2 ]
Bonnet, Sarah
Gay, Julie [2 ]
Debarri, Houria
Herbaux, Charles [3 ]
Michel, Jessica [1 ]
Perrot, Aurore [4 ]
Serrier, Caroline [1 ]
Robinson, Suzanne K. [5 ]
Miljkovic, Darko [6 ]
Morel, Pascale [6 ]
Boccacio, Catherine [6 ]
AvetLoiseau, Herve [7 ]
Facon, Thierry [2 ]
Hulin, Cyrille [1 ]
Leleu, Xavier [8 ]
机构：
[1] CHU Nancy, Nancy, France
[2] Hop Claude Huriez, Serv Malad Sang, Lille, France
[3] CHU Lille, F-59037 Lille, France
[4] CHU Hematol, Nancy, France
[5] Celgene Int, Boudry, Switzerland
[6] Celgene Corp, Nantes, France
[7] Hop Nantes, Dept Hematol, Nantes, France
[8] CHRU, Hop Claude Huriez, Serv Malad Sang, Lille, France
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2964.2964
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2964
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Lenalidomide for the treatment of relapsed multiple myeloma
    Gajraj, Elangovan
    Chung, Helen
    Boysen, Meindert
    Barnett, David B.
    Longson, Carole
    LANCET ONCOLOGY, 2009, 10 (07): : 647 - 648
  • [22] THE EFFICACY OF COMBINATION THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF RELAPSED MULTIPLE MYELOMA
    Szudy-Szczyrek, Aneta
    Legiec, Wojciech
    Manko, Joanna
    Gmyz, Katarzyna
    Szczyrek, Michal
    Hus, Marek
    HEALTH PROBLEMS OF CIVILIZATION, 2015, 9 (02) : 50 - 54
  • [23] Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: a real-life experience
    Soyer, Nur
    Patir, Pusem
    Uysal, Ayse
    Duran, Mustafa
    Unal, Hatice Demet
    Durusoy, Raika
    Tombuloglu, Murat
    Sahin, Fahri
    Tobu, Mahmut
    Vural, Filiz
    Saydam, Guray
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 777 - 785
  • [24] The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function
    Weber, D. M.
    Spencer, A.
    Wang, M.
    Chen, C.
    Attal, M.
    Niesvizky, R.
    Prince, M.
    Yu, Z.
    Knight, R.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] The Efficacy and Safety of Lenalidomide Plus Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function
    Dimopoulos, Meletios
    Alegre, Adrian
    Stadtmauer, Edward A.
    Goldschmidt, Hartmut
    Zonder, Jeffrey A.
    de Castro, Carlos M.
    Masliak, Zvenyslava
    Reece, Donna
    Olesnyckyj, Marta
    Yu, Zhinuan
    Weber, Donna M.
    CANCER, 2010, 116 (16) : 3807 - 3814
  • [26] Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy
    Baz, R.
    Walker, E.
    Karam, M. A.
    Choueiri, T. K.
    Jawde, R. A.
    Bruening, K.
    Reed, J.
    Faiman, B.
    Ellis, Y.
    Brand, C.
    Srkalovic, G.
    Andresen, S.
    Knight, R.
    Zeldis, J.
    Hussein, M. A.
    ANNALS OF ONCOLOGY, 2006, 17 (12) : 1766 - 1771
  • [27] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    White, Darrell
    LeBlanc, Richard
    Venner, Chritopher
    Bahlis, Nizar J.
    Lentzsch, Suzanne
    Gasparetto, Cristina J.
    Chen, Christine
    Lipe, Brea
    Sutherland, Heather
    Tuchman, Sascha
    Baljevic, Muhamed
    Kotb, Rami
    Sebag, Michael
    Callander, Nancy
    Bensinger, William
    Kai, Kazuharu
    Liu, Jianjun
    Sheehan, Heidi
    Estepan, Daniel Nova
    Shah, Jatin
    Schiller, Gary J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E55 - E55
  • [28] EFFICACY AND SAFETY OF LENALIDOMIDE IN THE TREATMENT OF MULTIPLE MYELOMA WITH RENAL INSUFFICIENCY
    Bernal, L.
    Bonafonte, E.
    Izquierdo, I.
    Aules, A.
    Malo, M.
    Olave, M.
    Azaceta, G.
    Gutierrez, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 628 - 629
  • [29] Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma
    Lalagianni, C. E.
    Neokleous, N.
    Vadikoliou, C.
    Papalexandri, A.
    Apostolou, C.
    Saloum, R.
    Anagnostopoulos, A.
    Fassas, A.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S26 - S26
  • [30] The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma
    贾亚静
    China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 189 - 189
12345